Cargando…
Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer
The small leucine-rich proteoglycan (SLRP) family is widely expressed in extracellular matrix and aggravates tumor progression. However, epiphycan (EPYC), as a member of the SLRPs family, its biological function in cancer has not been confirmed. Thus, we aimed to clarify the role of EPYC in progress...
Autores principales: | Deng, Lu, Wang, Dandan, Chen, Shouzhen, Hu, Weiguo, Zhang, Ru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650094/ https://www.ncbi.nlm.nih.gov/pubmed/34888227 http://dx.doi.org/10.3389/fonc.2021.653782 |
Ejemplares similares
-
LINC00152 Promotes Tumor Progression and Predicts Poor Prognosis by Stabilizing BCL6 From Degradation in the Epithelial Ovarian Cancer
por: Wang, Shunni, et al.
Publicado: (2020) -
Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ji, Jia, et al.
Publicado: (2018) -
CDC27-ODC1 Axis Promotes Metastasis, Accelerates Ferroptosis and Predicts Poor Prognosis in Neuroblastoma
por: Qiu, Lin, et al.
Publicado: (2022) -
MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal Carcinoma
por: Li, Xi-Zhao, et al.
Publicado: (2021) -
Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer
por: Liu, Shaoqiu, et al.
Publicado: (2021)